Leonie K. Ashman

Medicine · Health Sciences

47h-index7.5kcitations175works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cell Adhesion Molecules Research(63), Mast cells and histamine(55), Platelet Disorders and Treatments(34), Protein Degradation and Inhibitors(26), Click Chemistry and Applications(24)

Publications175 total

Data from Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model
2023Open Access
Supplementary Figure 3 from Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model
2023Open Access
Supplementary Figure 3 from Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model
2023Open Access
Data from Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model
2023Open Access
Supplementary Figure 2 from Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model
2023Open Access
Supplementary Figure 1 from Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model
2023Open Access
Supplementary Figure 1 from Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model
2023Open Access
Supplementary Figure 2 from Genetic Ablation of the Tetraspanin CD151 Reduces Spontaneous Metastatic Spread of Prostate Cancer in the TRAMP Model
2023Open Access
Supplementary Tables 1-3 from Colocalization of the Tetraspanins, CO-029 and CD151, with Integrins in Human Pancreatic Adenocarcinoma: Impact on Cell Motility
2023Open Access
Supplementary Tables 1-3 from Colocalization of the Tetraspanins, CO-029 and CD151, with Integrins in Human Pancreatic Adenocarcinoma: Impact on Cell Motility
2023Open Access
Supplementary Tables S1-S3 from Colocalization of the Tetraspanins, CO-029 and CD151, with Integrins in Human Pancreatic Adenocarcinoma: Impact on Cell Motility
2023Open Access
Data from Colocalization of the Tetraspanins, CO-029 and CD151, with Integrins in Human Pancreatic Adenocarcinoma: Impact on Cell Motility
2023Open Access
Data from Colocalization of the Tetraspanins, CO-029 and CD151, with Integrins in Human Pancreatic Adenocarcinoma: Impact on Cell Motility
2023Open Access
Supplementary Tables S1-S3 from Colocalization of the Tetraspanins, CO-029 and CD151, with Integrins in Human Pancreatic Adenocarcinoma: Impact on Cell Motility
2023Open Access
Supplementary Figure 10 from Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers
2023Open Access
Supplementary Figure Legends 1-10 from Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers
2023Open Access
Supplementary Figure 4 from Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers
2023Open Access
Supplementary Figure 3 from Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers
2023Open Access
Supplementary Figure 5 from Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers
2023Open Access
Supplementary Table 1 from Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT<sup>+</sup> Cancers
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Paul M. Sincock(5), Stephen Fitter(5), Mark D. Wright(5), Denise E. Jackson(4), Paulo Ferrão(4), Stephen R. Cole(3), Renate Griffith(3), Fedor Berditchevski(3), T Furitsu(2), Tohru Tsujimura(2), Hirokazu Ikeda(2), Joseph H. Butterfield(2), Yoshio Kanayama(2), Michelle J. Frost(2), Petranel T. Ferrão(2), Peter L. Ey(2), Sean M. Geary(2), Gregory W. Moseley(2), Lai-Man Lau(2), Kuo‐Ching Sheng(2)